Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,663.1
1.7 (0.06%)

 

  • STI Straits Times Index
    2,663.1
    1.7 (0.06%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,575.4
    8.7 (0.56%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,075.4
    99.8 (0.38%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,368.2
    22.9 (0.68%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,495.2
    -119.5 (-0.53%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,051.9
    64.8 (1.30%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 904.7M
  • Value: 456.8M
  • Rise: 149
  • Fall: 125
  • Unch: 535

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Singapore-eDev0.127+0.008
SinoCloud0.001-0.001
Wilton Resources0.040+0.007
BlackGoldNatural0.018+0.002
TEE Intl0.033+0.003
Medtecs Intl0.740+0.035
MDR0.001-
Ntegrator Intl0.010+0.001
AsiaMedic0.015-
Jasper Inv0.002-

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,246.6 -303.4
HSCEI 9,742.1 -111.1
Jakarta 4,863.1 -41.0
Nikkei 225 22,062.1 -450.0
SSE Comp 2,958.7 -11.9
Shanghai A 3,101.3 -12.4
Shanghai B 211.6 -1.8
KOSPI 2,098.0 -36.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

KEROS THERAPEUTICS INC KEROS THERAPEUTICS
Updated on 07 Jul 2020 (End of trading day)
Last (USD): 33.710 Change: -0.910 High: 35.170 Remarks: -
Change (%): -2.63 Low: 33.560
Open 34.680 Yesterday's Close 34.62
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 30,355 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.70158 Trailing EPS (USD) e -0.70158 NAV (USD) b -1.2342
PE a - Trailing PE f - Price / NAV b -27.3132
Dividend (USD) d - Cash In Hand (USD) g 2.7058 Issued & Paid-up Shares c 20,148,700
Dividend Yield (%) d - Price / Cash In Hand g 12.458 Treasury Shares h -
Market Cap (M) 679.213 Enterprise Value (M) 701.602
Piotroski F Score 1 Exchange Code KROS Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 52.3
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 22 May 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 03 Apr 2020.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference KEROS THERAPEUTICS INC NASDAQ 679.213 - - -27.3132 -
Industry Pharmaceuticals: Major NASDAQ 1,719.908 114.250 1786.655 2.9784 0.008
Local Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 129,030.670 39.657 39.657 1.9505 2.281
Local Peer ROYALTY PHARMA PLC NASDAQ 28,560.997 - - -22,404.7619 -
Local Peer REPLIGEN CORP NASDAQ 6,493.230 303.269 280.207 6.0698 -
Local Peer REATA PHARMACEUTICALS INC NASDAQ 5,226.108 - - 22.8566 -
Local Peer LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS NASDAQ 4,905.343 - - -29.4921 -
Local Peer GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 NASDAQ 4,888.648 6.987 6.313 0.8037 -
Local Peer NEKTAR THERAPEUTICS NASDAQ 4,296.679 - - 3.3142 -
Local Peer HUTCHISON CHINA MEDITECH SPON ADS EACH REPR 5 ORD SHS NASDAQ 4,118.493 - - 14.2998 -
Local Peer ALLAKOS INC NASDAQ 3,287.336 - - 6.8766 -
Local Peer KARUNA THERAPEUTICS INC NASDAQ 2,617.713 - - 6.8003 -
Local Peer TURNING POINT THERAPEUTICS INC NASDAQ 2,556.990 - - 6.6988 -
Local Peer OPKO HEALTH INC NASDAQ 2,565.445 - - 1.6566 -
Other Local Peers APELLIS PHARMACEUTICALS INC (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), PRINCIPIA BIOPHARMA INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), AKCEA THERAPEUTICS INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), CONSTELLATION PHARMACEUTICALS INC (NASDAQ), TRICIDA INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), ATHENEX INC (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), PETIQ INC (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), GENERATION BIO CO (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), PROVENTION BIO INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), AC IMMUNE SA (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), BEYONDSPRING INC (NASDAQ), IMARA INC (NASDAQ), BIOSPECIFICS TECHNOLOGIES CORP (NASDAQ), DURECT CORP (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), 89BIO INC (NASDAQ), UROVANT SCIENCES LTD (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), LIQUIDIA TECHNOLOGIES INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), AMAG PHARMACEUTICS INC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), MENLO THERAPEUTICS INC (NASDAQ), POLYPID LTD (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), GRITSTONE ONCOLOGY INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), VERU INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), IMMUNIC INC (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), EVOLUS INC (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), OBSEVA SA (NASDAQ), MUSTANG BIO INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), HARROW HEALTH INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), ESSA PHARMA INC (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), GENPREX INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), KITOV PHARMA LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), MEDIWOUND LTD (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), THE FS ALSEC ALPHASECTOR (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), LANTERN PHARMA INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), BAUDAX BIO INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), EYENOVIA INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), AERPIO PHARMACEUTICALS INC (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), NOVAN INC (NASDAQ), MANNATECH INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), HISTOGEN INC (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), ENTERA BIO LTD (NASDAQ), MILLENDO THERAPEUTICS INC (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), SPRING BANK PHARMACEUTICALS INC (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), PROPHASE LABS INC (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ), TELIGENT INC NEW (NASDAQ), NOVUS THERAPEUTICS INC (NASDAQ)
Global Peer JOHNSON & JOHNSON NYSE 376,351.182 24.893 21.924 6.1401 2.623
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 216,607.868 30.732 21.703 - 2.098
Global Peer MERCK & CO INC NYSE 198,697.152 20.187 19.582 7.5824 2.888
Global Peer PFIZER INC NYSE 189,030.865 11.617 11.972 2.9078 4.274
Global Peer ABBVIE INC NYSE 175,088.479 22.327 20.866 -23.6126 3.708
Global Peer ELI LILLY AND COMPANY NYSE 159,586.087 34.409 28.841 51.8340 1.548
Global Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NYSE 140,334.154 104.685 188.688 - 2.562
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 136,417.580 39.668 142.995 2.7332 2.744
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 117,925.154 20.196 19.626 14.7428 1.748
Global Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 101,298.883 17.095 21.002 - -
Other Global Peers TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), WUXI APPTEC (HKEx), HANSOH PHARMA (HKEx), INNOVENT BIO (HKEx), SINOPHARM (HKEx), CANSINOBIO-B (HKEx), SH PHARMA (HKEx), BAIYUNSHAN PH (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), CHINARES PHARMA (HKEx), HENLIUS-B (HKEx), AKESO-B (HKEx), ADC THERAPEUTICS SA (NYSE), CMS (HKEx), TRAD CHI MED (HKEx), CHINAGRANDPHARM (HKEx), HYGEIA HEALTH (HKEx), INNOCARE-B (HKEx), SSY GROUP (HKEx), ZYMEWORKS INC (NYSE), UNITED LAB (HKEx), CSTONE PHARMA-B (HKEx), AMNEAL PHARMACEUTICALS INC (NYSE), JUNSHI BIO-B (HKEx), TONGRENTANGCM (HKEx), CKLIFE SCIENCES (HKEx), HUA MEDICINE-B (HKEx), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), IGBB (Bursa), SHINEWAY PHARM (HKEx), Kimia Farma Tbk. (IDX), TOT BIOPHARM-B (HKEx), FUSEN PHARM (HKEx), STARPHARMA HOLDINGS LIMITED (ASX), LANNETT CO INC (NYSE), AFT PHARMACEUTICALS LTD (ASX), PYC THERAPEUTICS LIMITED (ASX), BSTEAD (Bursa), CH BIOTECH SER (HKEx), DAWNRAYS PHARMA (HKEx), PHARMA (Bursa), BIOMX INC (NYSE American), ZHONGZHIPHARM (HKEx), IX Biopharma (SGX), Merck Tbk. (IDX), PAK FAH YEOW (HKEx), NEW RAY MEDIC (HKEx), KOTRA (Bursa), CHARMACY PHAR (HKEx), NC HEALTHCARE (HKEx), IP (SET), ONCOSIL MEDICAL LIMITED (ASX), Phapros Tbk. (IDX), PALLA PHARMA LTD (ASX), RACE ONCOLOGY LTD (ASX), Hyphens Pharma (SGX), RECCE PHARMACEUTICALS LTD (ASX), NOVA (Bursa), NEP INTERLONG (HKEx), WAI YUEN TONG (HKEx), TBG DIAGNOSTICS LTD (ASX), PURAPHARM (HKEx), SANAI HEALTH GP (HKEx), INVION LTD (ASX), JCT (SET), AGEX THERAPEUTICS INC (NYSE American), IMMURON LIMITED (ASX), NOXOPHARM LTD (ASX), EXTRAWELL PHAR (HKEx), MEDLAB CLINICAL LIMITED (ASX), BIOHLDG (Bursa), ANNOVIS BIO INC (NYSE American), TIMBER PHARMACEUTICALS INC (NYSE American), SINOLIFE UTD (HKEx), PHARMAXIS (ASX), EXOPHARM LTD (ASX), ACRUX (ASX), PASHUN INT'L (HKEx), TALI DIGITAL LIMITED (ASX), CELLMID LIMITED (ASX), SUNZEN (Bursa), CRESO PHARMA LTD (ASX), Merck Sharp Dohme Pharma Tbk. (IDX), Pharmesis Intl (SGX), FIJI KAVA LTD (ASX), FARMAFORCE LTD (ASX), SUDA PHARMACEUTICALS LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --2.750
-7.54 %
10 Days --5.290
-13.56 %
20 Days --1.810
-5.10 %
Medium Term Return 3 Months -+13.630
+67.88 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 19.100 - 42.260 Change From 1 Year Low +14.610 % Change From 1 Year Low (%) +76.49
Change From 1 Year High -8.550 % Change From 1 Year High (%) -20.23
2 Years Range 19.100 - 42.260 Change From 2 Years Low +14.610 % Change From 2 Years Low (%) +76.49
Change From 2 Years High -8.550 % Change From 2 Years High (%) -20.23
5 Years Range 19.100 - 42.260 Change From 5 Years Low +14.610 % Change From 5 Years Low (%) +76.49
Change From 5 Years High -8.550 % Change From 5 Years High (%) -20.23
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Keros Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on treatments for rare muscle diseases. The company was founded in 2015 and is headquartered in Lexington, MA.

Historical Price Data

Date Open High Low Close Volume VWAP
07 Jul 2020 34.680 35.170 33.560 33.710 30,355 -
06 Jul 2020 36.370 36.370 34.040 34.620 66,775 -
02 Jul 2020 36.810 37.780 34.800 35.800 75,491 -
01 Jul 2020 36.069 39.204 35.510 36.460 182,955 -
30 Jun 2020 37.750 38.750 36.160 37.510 82,700 -
29 Jun 2020 39.530 40.019 37.390 38.000 78,164 -
26 Jun 2020 40.850 41.500 37.695 38.630 899,904 -
25 Jun 2020 39.540 42.260 39.360 40.390 150,383 -
24 Jun 2020 40.700 41.916 37.000 39.000 141,330 -
23 Jun 2020 38.090 41.980 37.500 40.210 220,418 -
22 Jun 2020 38.200 40.200 36.310 37.650 181,659 -
19 Jun 2020 36.800 40.630 35.910 38.520 465,189 -
18 Jun 2020 35.000 37.000 33.820 36.770 121,147 -
17 Jun 2020 36.090 37.000 35.250 35.290 114,386 -
16 Jun 2020 36.670 37.000 35.570 35.940 107,932 -
15 Jun 2020 34.180 39.115 33.980 35.560 119,300 -
12 Jun 2020 33.400 35.625 33.400 34.300 43,508 -
11 Jun 2020 34.340 34.340 33.025 33.720 156,510 -
10 Jun 2020 35.540 36.200 34.504 35.520 84,927 -
09 Jun 2020 34.590 37.400 33.415 35.810 56,525 -
08 Jun 2020 32.090 35.950 28.880 35.100 76,173 -
05 Jun 2020 33.510 34.165 31.690 31.830 42,937 -
Summary
Current 2 Weeks
(23 Jun 2020 to 07 Jul 2020)
38.090 42.260 33.560 33.710 1,928,475 -
Previous 2 Weeks
(09 Jun 2020 to 22 Jun 2020)
34.590 42.260 33.415 37.650 1,451,083 -
4 Weeks from
(11 May 2020 to 08 Jun 2020)
27.730 42.260 26.212 35.100 1,077,088 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.